146 related articles for article (PubMed ID: 9575460)
1. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis.
McCann J; Stockton D; Day N
J Med Screen; 1998; 5(1):42-8. PubMed ID: 9575460
[TBL] [Abstract][Full Text] [Related]
2. Predicted long-term mortality reduction associated with the second round of breast screening in East Anglia.
McCann J; Duffy S; Day N;
Br J Cancer; 2001 Feb; 84(3):423-8. PubMed ID: 11161411
[TBL] [Abstract][Full Text] [Related]
3. Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.
Day N; McCann J; Camilleri-Ferrante C; Britton P; Hurst G; Cush S; Duffy S
J Med Screen; 1995; 2(4):180-5. PubMed ID: 8719145
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the prevalent round of the breast screening programme in south east Thames, 1988-1993: achievement of quality standards and population impact.
Garvican L; Littlejohns P
J Med Screen; 1996; 3(3):123-8. PubMed ID: 8946306
[TBL] [Abstract][Full Text] [Related]
5. Interval cancers in the Dutch breast cancer screening programme.
Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
[TBL] [Abstract][Full Text] [Related]
6. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
7. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology.
Tabar L; Fagerberg G; Chen HH; Duffy SW; Gad A
J Med Screen; 1995; 2(2):94-8. PubMed ID: 7497163
[TBL] [Abstract][Full Text] [Related]
8. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
9. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
McCann J; Treasure P; Duffy S
J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
[TBL] [Abstract][Full Text] [Related]
10. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
11. The Scottish breast screening programme's experience of monitoring interval cancers.
Everington D; Gilbert FJ; Tyack C; Warner J
J Med Screen; 1999; 6(1):21-7. PubMed ID: 10321366
[TBL] [Abstract][Full Text] [Related]
12. Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: variation with time and impact on 10-year survival.
Lawrence G; O'Sullivan E; Kearins O; Tappenden N; Martin K; Wallis M
J Med Screen; 2009; 16(4):186-92. PubMed ID: 20054093
[TBL] [Abstract][Full Text] [Related]
13. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
[TBL] [Abstract][Full Text] [Related]
14. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma.
Zackrisson S; Andersson I; Manjer J; Janzon L
Int J Cancer; 2004 Feb; 108(5):754-60. PubMed ID: 14696103
[TBL] [Abstract][Full Text] [Related]
15. Interval breast cancers in the NHS Breast Screening Programme: does the current definition exclude too many?
Faux AM; Richardson DC; Lawrence GM; Wheaton ME; Wallis MG
J Med Screen; 1997; 4(3):169-73. PubMed ID: 9368875
[TBL] [Abstract][Full Text] [Related]
16. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
van Dijck JA; Hendriks JH; Holland R; Schouten LJ; Verbeek AL
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1119-24. PubMed ID: 10876707
[TBL] [Abstract][Full Text] [Related]
17. Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy.
Puliti D; Bucchi L; Mancini S; Paci E; Baracco S; Campari C; Canuti D; Cirilli C; Collina N; Conti GM; Di Felice E; Falcini F; Michiara M; Negri R; Ravaioli A; Sassoli De' Bianchi P; Serafini M; Zorzi M; Caldarella A; Cataliotti L; Zappa M;
Eur J Cancer; 2017 Apr; 75():109-116. PubMed ID: 28222306
[TBL] [Abstract][Full Text] [Related]
18. Update of the Swedish Two-County Trial of breast cancer screening: histologic grade-specific and age-specific results.
Tabar L; Vitak B; Chen HH; Prevost TC; Duffy SW
Swiss Surg; 1999; 5(5):199-204. PubMed ID: 10546517
[TBL] [Abstract][Full Text] [Related]
19. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme.
Blanks RG; Moss SM; Wallis MG
J Med Screen; 1996; 3(4):200-3. PubMed ID: 9041485
[TBL] [Abstract][Full Text] [Related]
20. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
